Cutaneous Prostate Adenocarcinoma Masquerading as Cellulitis

Main Article Content

Ariel Darnall
Rebecca Olsen
Dathan Hamann
Sarah Estrada

Keywords

prostate adenocarcinoma, cellulitis, cutaneous metastasis

Abstract

Cutaneous metastases of prostate cancer are a rare entity and mimic many other common cutaneous conditions such as cellulitis, zosteriform lesions, and many others, making it easy to misdiagnose. Recognition of this condition is vital to prevent delays in treatment, as lesions usually appear in late stages of the disease and are associated with a high fatality rate. Here we describe a case of a 64-year-old man with a history of diffuse metastatic prostate carcinoma, who presented with a suprapubic rash that was initially diagnosed as cellulitis but was later determined to be cutaneous metastasis. Clinical characteristics of this metastasis and common dermal lesions with similar clinical presentations are discussed. Clinicians should be aware of the characteristics of this cutaneous metastasis and consider it when evaluating skin lesions that mimic soft tissue infections.

References

1. U.S. Cancer Statistics Working Group. U.S. cancer statistics data visualizations tool, based on 2020 submission data (1999-2018): U.S. Department of Health and Human Services. Centers for Disease Control and Prevention and National Cancer Institute website. Updated June 2021. Accessed January 2022. www.cdc.gov/cancer/dataviz

2. Dills A, Obi O, Bustos K, et al. Cutaneous metastasis of prostate adenocarcinoma: a rare presentation of a common disease. J Investig Med High Impact Case Rep. 2021;9:2324709621990769.

3. Brown GT, Patel V, Lee CC. Cutaneous metastasis of prostate cancer: a case report and review of the literature with bioinformatics analysis of multiple healthcare delivery networks. J Cutan Pathol. 2014;41(6):524-528.

4. Krathen RA, Orengo IF, Rosen T. Cutaneous metastasis: A meta-analysis of data. South. Med. J. 2003;96(2): 164-167.

5. Araújo E, Barbosa M, Costa R, Sousa B, Costa V. A First Sign Not to be Missed: Cutaneous Metastasis from Breast Cancer. Eur J Case Rep Intern Med. 2020;7(1):001356.

6. Gurel B, Ali TZ, Montgomery EA, et al. NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol. 2010;34(8):1097-1105.

7. Miller RT. Cytokeratin AE1/AE3. Propath. Updated November 2003. Accessed March 21, 2022. https://www.who.int/medical_devices/diagnostics/selection_in-vitro/selection_in-vitro-meetings/00038_05_focus_nov_2003.pdf

8. Ferraro DA, Rüschoff JH, Muehlematter UJ, et al. Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with 68Ga-PSMA-11 PET. Theranostics. 2020;10(14):6082-6094.

9. Gorman BG, Hanson J, Vidal NY. The importance of palpation in the skin cancer screening examination. J. Cosmet. Dermatol. 2021;20(12): 3982-3985.

10. El Hayderi L, Libon F, Nikkels-Tassoudji N, et al. Zosteriform dermatoses-a review. Glob Dermatol. 2015;2(4):163-173.

11. Ko LN, Garza-Mayers AC, St John J, et al. Effect of dermatology consultation on outcomes for patients with presumed cellulitis: a randomized clinical trial. JAMA Dermatol. 2018;154(5):529-536.

12. Sullivan T, De Barra E. Diagnosis and management of cellulitis. Clin Med (Lond). 2018;18(2):160-163.

Most read articles by the same author(s)